Xenetic Biosciences annual gross margin
2012
2013
Xenetic Biosciences Gross Margin Growth & History (XBIO)
Xenetic Biosciences's gross margin was 100.00% for fiscal 2013.
View full Xenetic Biosciences company overviewXenetic Biosciences annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2013 · Dec 31 | 2013-12-31 | 100.00% | +15.27 pp |
| 2012 · Dec 31 | 2012-12-31 | 84.73% | — |
Xenetic Biosciences quarterly gross margin
Q3.12
Q2.13
Q2.13
Q3.17
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2017 | 2017-09-30 | −14.15% | — |
| Q2 2013 · Jun 30 | 2013-06-30 | 100.00% | — |
| Q2 2013 · May 31 | 2013-05-31 | 74.81% | −25.19 pp |
| Q3 2012 | 2012-05-31 | 100.00% | — |
Xenetic Biosciences gross margin trends
Between the periods ended 2012-12-31 and 2013-12-31, Xenetic Biosciences's gross margin increased from 84.73% to 100.00%, a change of +15.27 percentage points. The latest reported quarter, Q3 2017, shows −14.15%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xenetic Biosciences source filings ↗